Abbott voluntary admission: representative worked without passing ABPI Medical Representatives Examination (Clause 16.3)

📅 2008 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/2458/11/11
CompanyAbbott Laboratories Limited
IssueOne representative had not taken/passed the ABPI Medical Representatives Examination
How it came to lightInternal review of representatives’ certificates; voluntary admission to PMCPA
Applicable Code year2011
Breach clauses16.3
Complaint received17 November 2011
Case completed4 January 2012
AppealNo appeal
SanctionsUndertaking received (additional sanctions: Not stated)

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • Abbott Laboratories voluntarily advised the PMCPA that one of its representatives had not taken the ABPI Medical Representatives Examination.
  • The issue was identified during an internal review of representatives’ certificates.
  • The representative had entered the industry when a nursing qualification could exempt them from the exam, but that exemption was removed in 2006.
  • Previously exempt representatives had to be entered for the exam by January 2007 and pass by January 2008.
  • An internal 20 January 2006 email to regional managers highlighted that there were no longer any exemptions and asked for names of previously exempt staff.
  • The representative’s then manager replied that the team was “up to speed” on the changes; the Panel considered this ambiguous and that clarification should have been sought.
  • Abbott could not find formal documentation about the representative’s exam status when they joined; the manager later left the company.
  • Once discovered, the representative stopped working in the field until a resolution could be found.
⚖️

Outcome

  • Breach ruled (as acknowledged by Abbott).
  • The Panel ruled a breach of Clause 16.3 (representatives must pass the appropriate ABPI representatives’ examination within required time limits).
  • No appeal.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training